Skip to main content
. Author manuscript; available in PMC: 2014 Nov 1.
Published in final edited form as: J Endocrinol. 2014 Jun;221(3):R163–R176. doi: 10.1530/JOE-14-0039

Figure 8.

Figure 8

Effect of rhIGF-I +/− OCP on BMD. Administration of recombinant human insulin like growth factor-I (IGF-I) (30 mcg/kg b.i.d. subcutaneously) increased bone density in adult women with anorexia nervosa. The effect was most marked when IGF-I was given with a birth control pill (Reprinted with permission from the Journal of Clinical Endocrinology and Metabolism, 2002;87:2888. Copyright © 1999 The Endocrine Society. All rights reserved)